ESKEF yields 0.25% · MRK yields 2.76%● Live data
📍 ESKEF pulled ahead of the other in Year 8
Combined, ESKEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESKEF + MRK for your $10,000?
Esker SA provides SaaS-based document process automation solutions in France and internationally. The company offers procure-to-pay solutions, which includes supplier and contract management, procurement, AP automation, expense management, and payment and supply chain financing; and order-to-cash solutions, such as order and credit management, invoice delivery, payment, and collections management, as well as cash app and deductions. It also provides document delivery solutions, including cloud fax and mail, e-invoicing, and esker EDI services. In addition, the company offers document automation technologies, including Esker on Demand, a cloud-based document process and information exchange service that enables companies to automate business documents; and VSI-Fax, which provides faxing from enterprise applications along with email-integrated desktop faxing. Further, it provides host access products, which is a software enabling a group of PCs to communicate with a host system, and share peripherals, or access the associated databases; and business process outsourcing tool for incoming non-EDI orders or invoices. The company serves the life sciences, building material, food, electronics, and chemical industries. Esker SA was incorporated in 1985 and is headquartered in Lyon, France.
Full ESKEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.